Thyroid C-mobile Tumors: In rodent research, semaglutide is demonstrated to result in thyroid C-cell tumors. It can be unidentified whether or not this threat applies to individuals, but semaglutide is contraindicated in patients with a personal or household historical past of medullary thyroid carcinoma (MTC) or clients with Several Endocrine Neop